Real‐World Treatment Patterns and Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and 1–3 Prior Lines of Therapy: Optum Database

ABSTRACT Background Early (often continuous) treatment of multiple myeloma (MM) with lenalidomide has become common practice, leading to an increase in lenalidomide‐refractory disease. Methods We report real‐world treatment patterns, health care resource utilization (HCRU), and outcomes for patients...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Binod Dhakal, Hermann Einsele, Jordan M. Schecter, William Deraedt, Nikoletta Lendvai, Ana Slaughter, Carolina Lonardi, Sandhya Nair, Nirosha Elsem Varghese, Jianming He, Akshay Kharat, Seina Lee, Patricia Cost, Ravi Potluri, Mythili Koneru, Nitin Patel, Erika Florendo, Paula Rodriguez‐Otero, Kwee Yong
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2025-08-01
Schriftenreihe:	Cancer Medicine
Schlagworte:	health care resource utilization multiple myeloma real‐world outcomes refractory
Online-Zugang:	https://doi.org/10.1002/cam4.71093
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!